期刊文献+

肝细胞生长因子基因转染后对内皮祖细胞增殖、迁移、分泌一氧化氮及血管再生的影响 被引量:1

Effect of Transfected HGF Gene on the Abilities of Endothelial Progenitor Cells to Proliferate,Migrate,Secrete NO and Angiogenesis
暂未订购
导出
摘要 目的:本研究拟用肝细胞生长因子(HGF)基因修饰内皮祖细胞(EPCs),以观察其对 EPCs 增殖、迁移、分泌一氧化氮(NO)及生血管能力的影响。方法:采用梯度离心法分离并培养大鼠骨髓 EPCs,荧光 DiI 标记乙酰化低密度脂蛋白(DiI-acLDL)摄取和异硫氰酸荧光素标记的荆豆凝集素(FITC-UEA-I)结合荧光双染法鉴定大鼠 EPCs。细胞分为 HGF 转染组、阴性对照组及空白对照组,HGF 组用脂质体介导法导入 pIRES2-EGFP-HGF 质粒,阴性对照组导入 pIRES2-EGFP 质粒,空白对照组不导入质粒,然后用荧光显微镜观察绿色荧光蛋白的合成及逆转录多聚酶链反应(RT-PCR)检测细胞 HGF mRNA 的表达来鉴定转染的 EPCs。用四唑盐(MTF)法、改良的 Bodyen 小室及硝酸盐还原法观察细胞增殖、移行及分泌 NO 能力;体外成管试验用于分析细胞生血管的能力。结果:原代细胞培养4天后发现可成梭形贴壁细胞,7天后细胞成集落状,原代细胞培养21大左右接近融合并呈典型的鹅卵石样排列,细胞 DiI-LDL 摄取试验阳性,FITC-UEA-I 染色阳性。转染18h 后 HGF 转染组及阴性对照组细胞绿色荧光蛋白检测呈阳性,转染率为40%,而空白组则呈阴性。RT-PCR 结果显示,HGF 转染组细胞内 mRNA 的表达显著高于对照组,而空白对照及阴性对照组 HGF mRNA 表达无显著性差异。HGF 转染组细胞增殖、移行能力及分泌 NO 量均显著高于对照组。在 ECMatrix 培养基上培养12h,HGF 转染组体外成管评分显著高于对照组。结论:HGF 基因修饰能够显著提高 EPCs 增殖、移行、分泌 NO 及生血管能力,改善 EPCs 的生物学功能。 Objective :The aim of this study is to observe the effect of transfected HGF gene on the abilities of endotheliel progenitor cells (EPCs) to proliferate, migrate, secrete NO and angiogenesis. Methods : Rat bone marrow-derived EPCs were separated by gradient centrifugation of Ficoll and cultured, and then identified by dual-staining ceils positive for both lectin and DiI-acLDL. EPCs were divide into three groups:transfected HGF, negative con- trol and blank control. In transfected HGF group, pIRES2-EGFP-HGF was transfected into EPCs via mediation by liposome, pIRES2-EGFP was transfected into EPCs in negative control group. No plasmid was transfected in blank control group. After transfection, the synthesis of EGFP was observed by fluorescence microscope, and the expression of HGF mRNA in EPCs was detected by RT-PCR. MTT and modified Bodyen chamber and nitriate recovery were used respectively to mesure the abilities of EPCs to proliferate, migrate and secrete NO. In vitro tube-formation analysis also was used to evaluate the angiogenic ability of EPCs. Results:The spindle ceils were found on the fourth day. On the seventh day, the cluster of ceils appeared, and the ceils looked like "cobblestone" on the 21st day. Double positive for DiI-acLDL uptake and lectin binding by direct fluorescent staining were observed in the ceils. 18h after transfection, EGFP was positive in transfected HGF and negative group, and the rate of trans- fected EPCs was up to 40%. However, EGFP was negative in blank control group. Results of RT-PCR indicated that the expressions of HGF mRNA were significantly higher in transfected HGF group than that in negative and blank control group, and there were no different between negative and blank control group. The abilities of EPCs to proliferate, migrate and secrete NO in transfected HGF group were superior to that in negative and blank control group. 12h after culured on ECMatrix,the values of in vitro tube-formation analysis in transfected HGF group were significantly higher than those in negative and blank control group. Conclusions:The EPCs modified by HGF gene could enhance the abilities of proliferate, migrate, secrete NO and angiogenesis, and hence improve some biologic property of ECPs.
出处 《中国循环杂志》 CSCD 北大核心 2007年第6期468-472,共5页 Chinese Circulation Journal
基金 国家自然科学基金(批准号:30570765 30700889) 重庆市自然科学基金(批准号:CSTC 2005bb5304)资助
关键词 内皮祖细胞 肝细胞生长因子 基因转染 大鼠 Endothelial progenitor cells Hepatocyte growth factor Gene transfer Rat
  • 相关文献

参考文献12

  • 1Melo LG, Gnecchi M, Pachori AS, et al. Endothelium-Targeted gene and cell-based therapies for cardiovascular disease. Arterioscler Thromb Vase Boil,2004,24 (10) : 1761-1774.
  • 2Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res,2003,93(2) :e17-e24.
  • 3Kitta K, Day RM, Ikeda T, et al. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic Biol Med,2001,31 (7) :902-910.
  • 4Zhou YJ,Wang JH ,Zhang J. Hepatocyte growth factor protects human endothelial cells against advanced glycation end products-induced apoptosis. Biochem Biophys Res Commun ,2006,344(2) :658-666.
  • 5Vasa M, Fichtlseherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res,2001,89( 1 ) :E1 - E7.
  • 6黄培堂泽.分子克隆实验指南(上册).科学出版社,2002,30-32.
  • 7Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contribution to neovasculogenesis. Arterioscler Thromb Vasc Biol,2004,24 (2) :288 - 293.
  • 8Werner N, Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med,2006,10 (2) : 318 -332.
  • 9Son BR, Marquez-Curtis LA, Kucia M, et al. Migration of bone marrow and cord blood mesenchymal stem ceils in vitro is regulated by SDF-1- CXCR4 and HGF-c-met axes and involves matrix metalloproteinases.Stem Cells ,2006,24 (5) : 1254-1264.
  • 10张群伟,刘红军,段海峰,哈小琴,王华,贾向旭,鲁茁壮,吴祖泽,王立生.肝细胞生长因子对骨髓内皮祖细胞的动员作用[J].中国应用生理学杂志,2005,21(1):100-103. 被引量:7

二级参考文献30

  • 1Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization[J]. Circ Res, 1999 (85): 221-228.
  • 2Rafii S, Meeus S, Dias S, et al. Contribution of marrow-derived progenitors to vascular and cardiac regeneration[J]. Semin Cell Dev Biol, 2002(13): 61-67.
  • 3Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth[J]. Nat Med, 2001(7): 1194-1201.
  • 4Shi Q, Rafii S, Wu M H, et al. Evidence for circula-ting bone marrow-derived endothelial cells[J]. Blood, 1998(92): 362-367.
  • 5Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization[J]. Nat Med, 1999(5): 434-438.
  • 6Moore M A, Hattori K, Heissig B, et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1[J]. Ann N Y Acad Sci, 2001(938): 36-45.
  • 7Asahara T, Takahashi T, Masuda H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells[J]. EMBO J, 1999(18): 3964-3972.
  • 8Jiang W G, Hiscox S. Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles[J]. Histol Histopathol, 1997(12): 537-555.
  • 9Matsumoto K, Tajima H, Nakamura T. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth[J]. Biochem Biophys Res Commun, 1991(176): 45-51.
  • 10Toi M, Taniguchi T, Ueno T, et al. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer[J]. Clin Cancer Res, 1998(4): 659-664.

共引文献8

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部